why choose us

First received: March 26, 2023

Clinical Trial: Efficacy and Safety of Telitacicept in Early SLE

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lupus Erythematosus, Systemic

Study Type: INTERVENTIONAL


Official Title: A Study of Telitacicept in the Treatment of Early Stage Systemic Lupus Erythematosus

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of Telitacicept in adult patients with early stage of SLE .

Read more